May 2nd - 4th, 2018

Paris, France


Who else is coming » Marcel van Raaij

Director Pharmaceutical Affairs & Medical Technology
Dutch Ministry of Health

Marcel van Raaij studied Medical Biology at the State University of Leiden (The Netherlands) and received his PhD in Physiology at the same university.

After his PhD he moved to the field of toxicological risk assessment stationed at the National Institute of Public Health and Environment (RIVM). He was active in various international working groups and commissions (EU,WHO, OECD, US EPA) dealing with regulatory frameworks on e.g. pesticides, biocides and accidental exposures to (industrial) chemicals. After leading the Center for Integrated Risk Assessment for a number of years at RIVM, he became acting director for Nutrition, Medicines and Consumer Safety. From 2011 to 2014 he was Director of Environment and Safety at RIVM dealing with environmental policy and physical safety including preparedness and response activities. 

In October 2014 Marcel van Raaij was appointed as Director of Pharmaceutical Affairs and Medical Technology at the Ministry of Health in the Netherlands. The Directorate is responsible for the policy making on pharmaceuticals (from innovation, market access, safe use to pricing and reimbursement), medical devices and technology and tissues and cells including organ donation policy. The Netherlands presented a new Pharma policy in January 2016.

featured speakers »